MURRAY REPORTβœ‰ Free Email News Alerts← world desk
NEWS   /   WORLD NEWS

Joint statement between Australia and the UK on life sciences and biotechnology cooperation

Australia and the United Kingdom reaffirm their commitment to bilateral cooperation in life sciences and biotechnology.

Meeting in Canberra on 15 September 2026, representatives of both governments agreed to continue cooperation across the life sciences ecosystem, recognising its importance to improving health outcomes, driving innovation-led growth, attracting investment, and creating high-value jobs.

Australia and the United Kingdom share world-class capabilities in health and medical research, clinical development, biotechnology innovation, advanced manufacturing, and commercialisation. Both countries recognise the value of connecting researchers, clinicians, regulators, investors, and industry to translate scientific discoveries into safe and effective products, services and treatments that benefit patients and support economic growth.

Since the inaugural Strategic Innovation Dialogue in London in April 2024, life sciences have remained a specific priority for bilateral innovation cooperation. Australia and the United Kingdom have strengthened engagement across government, research and industry and identified opportunities across the life sciences value chain, from research and clinical validation through to regulation, commercialisation, investment, and market access.

Both countries will advance cooperation in areas including clinical trials, genomics and precision medicine, biotechnology innovation, digital health, advanced therapies, regulatory excellence, and pathways to commercialisation. This cooperation will support more efficient development pathways, stronger partnerships, and greater opportunities for innovative companies in both markets.